AstraZeneca vaccine: Most Australian recipients report some kind of reaction
Meanwhile Europe douses concern over increased thrombotic events with the COVID-19 vaccine, except for two rare types
About three out of four Australian recipients of AstraZeneca’s COVID-19 vaccine have experienced at least one adverse event, most commonly fatigue or headaches, new data show.
In addition, some 2.4% of the first 4000 recipients sought medical advice after getting their first dose of the adenovirus vector vaccine, the surveillance reveals.
